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Abstract
Background: RNAseq technology is replacing microarray technology as the tool of choice for gene expression
profiling. While providing much richer data than microarray, analysis of RNAseq data has been much more
challenging. To date, there has not been a consensus on the best approach for conducting robust RNAseq analysis.
Results: In this study, we designed a thorough experiment to evaluate six read count-based RNAseq analysis
methods (DESeq, DEGseq, edgeR, NBPSeq, TSPM and baySeq) using both real and simulated data. We found the
six methods produce similar fold changes and reasonable overlapping of differentially expressed genes based on
p-values. However, all six methods suffer from over-sensitivity.
Conclusions: Based on the evaluation of runtime using real data and area under the receiver operating
characteristic curve (AUC-ROC) using simulated data, we found that edgeR achieves a better balance between
speed and accuracy than the other methods.
Background
The process by which information from a gene is used in
the synthesis of a functional gene product is called gene
expression. The process of gene expression is used by all
known life including eukaryotes, prokaryotes, and viruses
to generate the macromolecular machinery for life. Gene
expression analysis is essential for biomedical research.
The introduction of microarray technology has helped
biomedical research make significant advances in the last
decade by allowing high-throughput gene expression
screening on all known genes. Recently, the introduction
of RNAseq technology has had a revolutionary impact on
the field of expression research. RNAseq refers to the use
of next-generation sequencing (NGS) technologies to
sequence cDNA in order to get information about a sam-
ple’s RNA content. Compared to microarray technology,
the RNAseq method offers several distinct advantages.
First, the detection range of RNAseq is not limited to a
set of predetermined probes as with microarray technol-
ogy, so RNAseq is capable of identifying new genes.
Second, the resolution of a microarray is limited to the
gene level for most arrays and the exon level for specially
designed exon arrays. On the other hand, RNAseq can
detect expression at the gene, exon, transcript, and cod-
ing DNA sequence (CDS) levels. Finally and most impor-
tantly, RNAseq can detect structural variants such as
alternative splicing and gene fusion. With the maturity of
NGS technologies, the price of RNAseq has become
comparable to microarrays. Many researchers have pre-
dicted the inevitable replacement of microarray by RNA-
seq [1-3] based on the competitive price and additional
genomic information contained in RNAseq data.
With the rich genomic information RNAseq technology
brings, it also comes with complication in the analysis phase.
To date, the research community has not yet come to a con-
sensus on the best approach for analyzing RNAseq data. The
most popular normalization method for microarray data is
Robust Multi-array Average (RMA) [4], a form of quantile
normalization. For RNAseq, one of the popular normaliza-
tion methods is Reads per Kilobase per Million mapped
reads (RPKM) [5] or Fragments Per Kilobase of transcript
per Million mapped reads (FPKM) [6]. The RPKM of a gene* Correspondence: yan.guo@vanderbilt.edu; yu.shyr@Vanderbilt.Edu
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is computed as follows: RPKM = 109 × C
N ∗ L, where C is
the number of reads mapped to the gene, N is the total
number of reads mapped to all genes, and L is the length of
the gene. FPKM is computed similarly to RPKM, except it
accounts for the scenario in which only 1 end of a paired-
end read is mapped. In addition to RPKM and FPKM, other
read count methods based on Possion, negative binomial,
and Bayesian methods also exist. Each method has unique
strengths and weaknesses. In this study, we focus on read
count-based methods and systematically evaluate 6 RNAseq
R packages including DESeq [7], DEGseq [8], edgeR [9], bay-
Seq [10], TSPM [11] and NBPSeq [12] using both real and
simulated data. BaySeq is considered an empirical Bayes
approach to detect patterns of differential expression, DESeq
and NBPSeq are based on a negative binomial model, DEG-
seq and TSPM are based on a Poisson model, and edgeR
uses empirical Bayes estimation and exact tests based on the
negative binomial.
Method
The real RNAseq datasets were selected from The Cancer
Genome Atlas (TCGA) [13,14]. TCGA is a massive, com-
prehensive, and collaborative project to catalogue genomic
data for over 20 types of cancers by the National Cancer
Institute (NCI), the National Human Genome Research
Institute (NHGRI), and 27 institutes and centers of the
National Institute of Health (NIH). Gene expression profil-
ing by RNAseq is one of the major components of geno-
mic data collected by TCGA. Breast cancer is the only
cancer type in TCGA that collected expression data on a
large quantity of tumor-normal paired samples. Thus we
selected breast cancer tumor-normal paired data (53 pairs)
as our primary source of real RNAseq data. Differentially
expressed genes between tumor and normal were identi-
fied using all six methods at the significance level of 0.05
with Benjamin-Hochberg False discovery rate (BH FDR)
adjustment. To evaluate the consistency between the six
methods, we computed pairwise Spearman’s correlations
as well as intraclass correlation (ICC) for fold change
values of all genes, along with the corresponding p-values.
In addition, we evaluated each method’s running time.
For each gene, the count is drawn from the negative
binomial distribution with the mean and dispersion para-
meters estimated from the TCGA breast cancer dataset.
For a given gene m, the fold change is calculated as
(ρm + ρ∗)dm where ρm is drawn from the gamma distribu-
tion with shape parameter 0.87 and rate parameter 1.36
(parameters are estimated from the TCGA breast cancer




1 , if genem is upregulated
−1, if genem is downregulated
0 , otherwise
.
We evaluated the methods using datasets simulated to
present different scenarios corresponding to a given com-
bination of the following parameters: sample size (5 or
10), proportion of differentially expressed genes (5% or
10%), ratio of up-regulated vs. down-regulated (1:1 or
3:1), lower bound of fold change (1.5 or 1.1), and lower
bound of depth (5 or 1). A total of the seven most repre-
sentative scenarios are shown in Table 1. For each sce-
nario, 30 datasets were simulated from a negative
binomial distribution. To evaluate the performance of
the six methods, we calculated the number of genes that
are significantly differentially expressed (NS), the rate of
false positives (FPR), and the rate of true positives (TPR)
across 30 simulation datasets for each scenario. False dis-
covery rate (FDR) at levels of 0.1, 0.05 and 0.01 were
used as the cutoffs. In order to measure the overall per-
formance, we also computed the area under the curve
(AUC) across 30 simulation datasets under each scenario.
Results and discussion
We performed differential expression analysis on the 53
tumor-normal paired samples from TCGA using all six
methods. Out of 16,146 genes, DEGseq identified the
most number of significant genes at 15,226. That is, 94.3%
of all genes were identified by DEGseq as statistically
significantly differentially expressed between tumor and
normal, which implies that DEGseq is over-sensitive.
DESeq on the other hand identified the least number of
differentially expressed genes with 7,171, which is still too
many to be biologically plausible. NBPSeq, edgeR, TSPM,
and baySeq identified 10,017, 10,457, 9,519, and 13,203
differentially expressed genes respectively (Figure 1). In
terms of up-regulated genes vs. down-regulated genes,
DESeq, edgeR, and NBPSeq identified more up-regulated
genes, while TSPM and DEGseq identified more down-
regulated genes. BaySeq does not provide fold change or
test statistics, thus no direction of gene expression change
can be determined through p-value alone. A unique char-
acteristic associated with baySeq is that there is a randomi-
zation factor built into its computation model. Using
baySeq to analyze the same dataset on same parameter
settings twice will generate slightly different results. In our
scenario, the difference can be as many as 100 genes.
Next we computed the overlap of differentially
expressed genes between methods for both up-regulated
and down-regulated genes. BaySeq was excluded from
this analysis due to its lack of directionality (Figure 2).
For down-regulated genes, 2,521 were identified by the
rest of five methods, and for up-regulated genes, 4,067
were identified by all five methods. DESeq, edgeR, and
NBPSeq observed the fewest singleton genes (defined as
genes identified by only 1 method) in terms of both up-
regulated and down-regulated genes. TSPM observed a
moderate number of singleton genes, and DEGseq
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observed the most, which is also a reflection of its over-
sensitivity.
We studied the relationship of fold change and p-value
vs. identification frequency of significantly expressed genes
detected by the six methods (Figure 3). As expected, genes
identified by all six methods had a stronger signal (e.g., a
higher fold change value) than genes identified by fewer
methods. The singleton genes had the lowest fold change
values (Figure 3 left). However, for p-value the pattern was
not clear. No significant association between p-value and
identification frequency was observed.
We also tested the consistency among the six methods
at overall significance levels. Pair-wise Spearman’s corre-
lation coefficient of fold change values was computed
(Figure 4). Most correlation coefficients are very close to
1, which indicates that the six methods are highly con-
sistent in terms of ranking genes according to fold
change despite difference in normalization method. We
also computed intraclass correlation coefficients (ICC)
using both fold change and p-value as well. The ICC
based on fold change was 0.975 which strongly suggests
that a high degree of agreement among the five methods
(excluding baySeq because no fold change can be calcu-
lated) as the fold change value is only affected by differ-
ent normalization techniques used by different methods
(Figure 5) However, the ICC for p-value was only 0.50,
indicating that these methods have a low agreement in
terms of ranking the differentially expressed genes. In
addition, baySeq produced the worst p-value correlation
with regard to the other methods. To assess accuracy,
one has to know a priori which genes are differentially
expressed between normal and tumor. Hence, we can
only calculate it in a simulation.
For simulated data, we compared the number of genes
that are significantly differentially expressed. In contrast to
the results from real data, baySeq identified the smallest
number of differentially expressed genes, while DEGseq
identified largest number of differentially expressed genes,
significantly more than other methods (Table 2). DESeq,
edgeR and NBPSeq identified similar numbers of differen-
tially expressed genes. The similar performance of DESeq,
edgeR, and NBPseq is probably due to the fact that these
methods are based on similar principles except the estima-
tion of the dispersion parameter. Among all six methods,
baySeq has the smallest FPR, and DEGseq has the largest
FPR. This indicates that baySeq was more conservative
compared to other methods. Among DESeq, edgeR and
NBPSeq, the largest FPR was found by NBPSeq, followed
by DESeq or edgeR. In general, the FPR of DESeq was
smaller than the FPR of edgeR. For TPR, the largest TPR
was found by DEGseq (i.e. it also found too many false
positives), followed by TSPM. As expected, DESeq, edgeR
and NBPSeq obtained similar results in TPR. After com-
paring the results under scenarios I and II, we found that
sample size has a large effect, especially for TPR. As sam-
ple size decreases, NS decreases, FPR increases, and TPR
decreases, respectively. TSPM shows the strongest effects
on sample size among the methods. After comparing the
results under scenarios I and III, we found that the pro-
portion of differentially expressed genes has a relatively
small effect on FPR and TPR for all methods. As the pro-
portion decreases, all of NS, FPR, and TPR decrease. After
comparing the results under scenarios I and IV, we found
that the proportions of up-regulated and down-regulated
genes have a large effect on NS and FPR for TSPM and
NBPSeq. After comparing the results under scenarios I, V,
and VI, we found that the level of treatment effects and
depth of reads have small effects for all of the methods
under reasonable sample size. Comparing the results
Table 1 Scenarios in the simulation comparison study
Scenario Sample size DE (%) Up/down Lower bound of fold change Lower bound of depth
I 10 10 1:1 1.5 5
II 2 10 1:1 1.5 5
III 10 5 1:1 1.5 5
IV 10 10 3:1 1.5 5
V 10 10 1:1 1.1 5
VI 10 10 1:1 1.5 1
VII 2 10 1:1 1.1 1
Figure 1 Number of significantly differentially expressed up-
regulated and down-regulated genes for each method.
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under scenarios I and VII, all methods are sensitive to the
sample size, level of treatment effects, and depth.
In Table 3, we summarized the average AUC-ROC for
each scenario. For each scenario, DEGseq has less satisfy-
ing performance compared to the other methods. Under
scenarios II, V, and VII, the average AUC-ROC of baySeq
was the largest. Those three scenarios were simulated for
the dataset with small sample size or small treatment
effects. This indicates that baySeq is the best performing
method when the dataset has a small sample size or small
treatment effect. Under other scenarios (i.e. I, III, IV, VI),
the best performance was generally obtained by edgeR and
DESeq, followed by NBPSeq and TSPM.
We also measured the runtime for each method run-
ning on the TCGA breast cancer dataset. On a Dell 3500
with a 2.8GHz CPU and 12 GB RAM, DESeq took the
most time to finish with over 2 hours followed by
NBPSeq (77 minutes), baySeq (47 minutes). TSPM and
edgeR took significantly less time in comparison with 6
and 2 minutes, respectively. DEGseq was the speediest of
the six, finishing in only 12 seconds. Combining informa-
tion from both runtime and AUC, edgeR performed best
with relatively short runtime and good AUC-ROC.
Conclusions
In this study, we systematically evaluated six read count-
based RNAseq analysis methods using both real and
simulated data. BaySeq is the most unique method out of
the six, because it is based on an empirical Bayesian
approach which produces no fold change or test statistics
Figure 2 Venn diagram of the overlap in differentially up-regulated and down-regulated genes among five methods (excluding baySeq).
Figure 3 The relationship of fold change and p-value vs. identification frequency.
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to infer the direction of the gene expression difference.
This inconvenient feature of baySeq forces users to go
back to the raw expression value to determine the direc-
tion. Another unique characteristic of baySeq is the ran-
domization steps involved in its model. For the same
data with the same parameter settings, baySeq produces
slightly different results. Granted, genes with the stron-
gest fold change will always be detected by baySeq, but
this minor inconsistency between runs of baySeq does
produce some inconvenience. From our simulation study,
we found that the performances of DESeq, edgeR, and
NBPSeq are similar in most cases. This result is expected
because all three methods are based on a negative bino-
mial model and differ principally in the way the disper-
sion parameter is estimated.
One of the issues we observed with these six read
count-based RNAseq analysis methods is that they tend
to be over-sensitive. For a traditional microarray study,
the number of differentially expressed genes identified
by a simple method such as a t-test is highly dependent
on the sample size. We have tested these six methods
using smaller sample sizes such as 2 vs. 2, but the
majority of the methods still produced huge amounts of
differentially expressed genes (sometimes over 50% of
total genes), which is a clear sign of over-sensitivity.
Through more thorough analysis, we found that the five
methods (excluding baySeq) produced very similar fold
changes but less similar ranks of p-value. Given these
facts, we would recommend using the combined criteria
of fold change and p-value to filter out more false posi-
tives. Combined with evaluation of runtime from real
data and AUC-ROC from simulated data, edgeR
achieved a good balance between speed and accuracy.
We are far from reaching a consensus on the best
RNAseq analysis approach. Several unique characteris-
tics of RNAseq data contribute to the difficulty of RNA-
seq data analysis. The value for non-expression in
RNAseq is zero, which means there are no reads aligned
to the gene. In microarray, there is always background
intensity for non-expressed genes, thus we can always
take log transformations of the intensity data. In con-
trast, due to the large number of zeros in RNAseq data
(often more than 50%), we cannot take a log transfor-
mation. The range of RNAseq data is between 0 and
50,000, compared to microarray’s 2 to 15 after RMA
normalization. This huge range of RNAseq data can
result in many false high fold changes. Also, there are
many sequencing and alignment artifacts that can skew
Figure 4 Pair-wise Spearman’s correlation coefficients of fold change computed among six methods.
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Figure 5 Intraclass correlation coefficients among six methods using fold change and p-value.
Table 2 Performance comparison under different scenarios
FDR = 0.1 FDR = 0.05 FDR = 0.01
Ns FPR TPR Ns FPR TPR Ns FPR TPR
I DESeq 759 0.0090 0.6779 679 0.0054 0.6304 550 0.0020 0.5316
Edger 825 0.0115 0.7216 740 0.0068 0.6799 614 0.0023 0.5934
DEGseq 8814 0.8735 0.9532 8864 0.8573 0.8573 8415 0.8306 0.9402
NBPSeq 1167 0.0480 0.7346 972 0.0322 0.6828 723 0.0153 0.5850
Bayseq 729 0.0060 0.6750 654 0.0027 0.6296 543 0.0006 0.5384
TSPM 2307 0.1687 0.7893 1815 0.0120 0.7306 1202 0.0663 0.6050
II DESeq 289 0.0153 0.1515 175 0.0096 0.0890 59 0.0037 0.0255
Edger 239 0.0138 0.1139 130 0.0080 0.0580 38 0.0028 0.0127
DEGseq 8379 0.8292 0.9162 8215 0.8119 0.9081 7921 0.7801 0.8923
NBPSeq 308 0.0207 0.1219 194 0.0134 0.0729 70 0.0054 0.0213
Bayseq 189 0.0070 0.1260 88 0.0029 0.0617 10 0.0003 0.0067
TSPM 291 0.0262 0.0557 262 0.0234 0.0513 217 0.0191 0.0447
III DESeq 363 0.0056 0.6200 319 0.0034 0.5739 255 0.0013 0.4860
Edger 401 0.0068 0.6729 354 0.0041 0.6301 284 0.0014 0.5414
DEGseq 8451 0.8391 0.9598 8288 0.8222 0.9555 8002 0.7925 0.9462
NBPSeq 567 0.0241 0.6767 474 0.0169 0.6283 346 0.0084 0.5335
Bayseq 332 0.0031 0.6052 295 0.0015 0.5615 242 0.0004 0.4763
TSPM 851 0.0529 0.6892 651 0.0354 0.6311 426 0.018 0.5035
IV DESeq 758 0.0090 0.6770 678 0.0055 0.6290 544 0.0019 0.5269
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RNAseq data. For example, GC content plays an impor-
tant factor in the sequenceability of a gene, and the
exon’s length has a large effect on alignment accuracy.
To date, only 1 RNAseq package, DESeq takes the
paired data information into consideration. In summary,
even though there are a large number of RNAseq analy-
sis tools at our disposal, given the uniqueness of RNA-
seq data and the number of unsolved problems, there is
still much room left to improve RNAseq analysis.
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